FindTrial
Sign In

Clinical trial of Qurs e Isqeel in congestive heart failure imtelai as an adjuvant therapy-A double blind study

Clinical efficacy of Qurs e Isqeel in Saqoot e Qalb imtelai as an adjuvant therapy-A double blind study - CEQISQIATDBS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037052
Enrollment
100
Registered
2021-10-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I508- Other heart failure

Interventions

None listed

Sponsors

Department of Moalejat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of both sexes Patients diagnosed with heart failure with a reduced ejection fraction.

Exclusion criteria

Exclusion criteria: Additional co-morbid diseases like of chronic liver and renal diseases

Design outcomes

Primary

MeasureTime frame
Increase in ejection fraction of post MI heart failure patientsTimepoint: every 30 days for three months—

Secondary

MeasureTime frame
Subjective Parameters, breathlessness, chest painTimepoint: every 30 days for three months—

Countries

India

Contacts

Public ContactHina Muqeem

Aligarh Muslim University

drbdkhanamu@gmail.com9412333174

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026